Yale Bulletin and Calendar

November 12, 2004|Volume 33, Number 11

Study enhances understanding of
enzyme's role in psychiatric illnesses

Overactivity of protein kinase C (PKC), an enzyme that is implicated in bipolar disorder and schizophrenia, markedly impairs higher brain functions in animals, according to a Yale study published Oct. 29 in Science.

The research adds to mounting evidence that excessive activity of PKC may underlie the distractibility, impaired judgment, impulsivity and disturbed thinking seen in bipolar disorder (also known as manic depressive illness) and in schizophrenia.

The study also shows that exposure to mild stress can activate PKC, which may lead to worsening of symptoms in patients with these disorders. The findings may explain how upsetting events in the environment can lead to deterioration in higher brain function, and why patients with schizophrenia or bipolar disorder may be particularly susceptible to stress-induced dysfunction. PKC inhibitors may be useful in treating these illnesses, according to Amy Arnsten, associate professor in the Department of Neurobiology at the School of Medicine and senior author of the study.

"These new findings may also help us understand the impulsivity and distractibility observed in children with lead poisoning," Arnsten says. "Very low levels of lead can activate PKC, and this may lead to impaired regulation of behavior."

Recent genetic and biochemical studies indicate that bipolar disorder and schizophrenia are associated with overactivity of PKC, and many medications that treat schizophrenia and bipolar disorder reduce PKC activity. However, the link between PKC overactivity and neuropsychiatric symptoms had not been understood.

This study examined the effects of increasing PKC activity in the prefrontal cortex of animals performing working memory tasks. The prefrontal cortex is a brain region that allows for the regulation of thoughts, behaviors and feelings. It becomes dysfunctional in both bipolar disorder and schizophrenia. In animals, either direct or indirect activation of PKC dramatically impaired prefrontal cortical function, while inhibition of PKC protected prefrontal function. No changes in performance were seen on cognitive tasks that did not rely on the prefrontal cortex.

-- By Jacqueline Weaver

T H I SW E E K ' SS T O R I E S

Yale to pay fee for students seeking visas

Pagnam steps down as V.P. for Development

Reception for donors will feature prizes, departmental awards

In Focus: Yale Urban Design Workshop

Medical School welcomes new deputy dean: Jaclyne Boyden

YCIAS event will honor new Leitner Professor

New database has info on all grants at Yale

The presidential election is topic of Poynter Lecture by CNN anchor

Noted surgeon displays his artistic side in sculpture exhibit

Alumni to explore Asian Americans' new role 'in the spotlight'

Environmental experts will explore the effects of the U.S. elections

Exhibit illuminates architects' work with 'Light Structures'

First talk in new series to explore gender studies in global context

Study links low education level with impaired recovery from illness

Researcher's grants support the development of statistical methods

Study enhances understanding of enzyme's role in psychiatric illnesses

Study shows spinal cord nerves regenerate despite absence of NgR protein

Journal fostering international dialogue . . .

Yale Books in Brief

Campus Notes